In total, NIH has awarded the project over $30 million. Researchers are hopeful that the funding will help pave the way for more personalized treatments for Alzheimer's.
ACC.26 Chair Kathryn Berlacher, MD, MS, explained some of the big trends at this year's meeting, including AI, CCTA, hands-on training and guideline sessions.
Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.
The STOP-CA trial showed that statins can help chemotherapy patients avoid potential side effects related to anthracycline agents. Co-principal investigators Marielle Scherrer-Crosbie, MD, and Tomas Neilan, MD, discussed the details of that trial at ACC.23.
The FDA-led Sentinel Initiative is tapping Oracle’s life-sciences division, Cerner Enviza, to spearhead development of AI tools for rendering EHR-bound clinical notes as usable pointers for clinicians and researchers.
People suddenly stricken with a cardiovascular crisis often survive and recover as long as they’re transported ASAP to a hospital that has two attributes: expertise in emergency heart care and capacity to accommodate the incoming episode.
